Inactive Instrument

Calendar XSPY PHAR Nasdaq Stockholm

Equities

SE0009973563

Chart calendar XSPY PHAR

7b0.wtmuVXkMuI2fZE2Uk_FK1Cw8yw46dnkcgcNy8ZQq8T4.qLqXDTN1ys_6BwPb8YEOrBVKujdJPRty14I5mNZDm0mnk_YPJkbA39oMAA~fb5e7a3d4a2cd5f2cd3958aa95a933b5

Upcoming events on XSPY PHAR

07/08/2024 Q2 2024 Earnings Release
06/11/2024 Q3 2024 Earnings Release
12/02/2025 Q4 2024 Earnings Release
01/05/2025 Q1 2025 Earnings Release (Projected)
01/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)
18/02/2026 Q4 2025 Earnings Release (Projected)

Past events on XSPY PHAR

03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No :6561
21/05/2024 01:30 pm Annual General Meeting
08/05/2024 Q1 2024 Earnings Release
20/03/2024 03:40 pm Redeye Theme: Commercialization in Life Science
14/02/2024 Q4 2023 Earnings Release
24/01/2024 05:49 pm Redeye Theme: Fight Cancer
08/11/2023 Q3 2023 Earnings Release
02/08/2023 Q2 2023 Earnings Release
01/06/2023 09:30 am Redeye Growth Day
25/05/2023 Extraordinary Shareholders Meeting
16/05/2023 01:30 pm Annual General Meeting
04/05/2023 Q1 2023 Earnings Release
07/03/2023 Redeye Commercialization Conference
15/02/2023 FY 2022 Earnings Release
19/01/2023 10:30 am Redeye Fight Cancer Seminar
13/12/2022 04:30 am American Society of Hematology Meeting
27/11/2022 Redeye Life Science Day_Interview
09/11/2022 Q3 2022 Earnings Release
07/09/2022 Pareto Securities Healthcare Conference
05/08/2022 12:00 pm Interim 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,42
-
0,00
0,22
-

713

EBITDA
Million SEK
Released
Forecast
Spread
-41,8
-72,0
42%
0,00


-89,1
-63,8
-39.57%
-124
-239
48.33%
-173
-153
-12.44%

-278

EBIT
Million SEK
Released
Forecast
Spread
-46,6
-73,0
36.21%
0,00


-98,0
-68,3
-43.36%
-133
-239
44.34%
-182
-230
20.99%

-293

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-45,8
-73,0
37.3%
0,00


-96,7
-75,4
-28.2%
-132
-238
44.64%
-180
-88,9
-102.08%

754

Net income
Million SEK
Released
Forecast
Spread
-45,8
-73,0
37.3%
-52,4


-96,7
-75,4
-28.2%
-132
-238
44.64%
-180
-88,9
-102.06%

596

EPS
SEK
Released
Forecast
Spread
-3,01
0,00
-
-3,05


-5,03
-3,96
-27.05%
-6,25
-8,55
26.88%
-6,76
-3,20
-111.53%

21,4

Announcement Date28/02/2025/02/2118/02/2215/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4
EBITDA
Million SEK
Released
Forecast
Spread
-17,0
-60,0
71.73%
-26,8
-22,0
-21.92%
-26,6
-60,0
55.68%
-53,2
-60,0
11.4%
EBIT
Million SEK
Released
Forecast
Spread
-19,3
-60,0
67.86%
-29,2
-22,0
-32.77%
-29,0
-60,0
51.68%
-55,6
-60,0
7.36%
Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-18,9
-59,0
67.91%
-28,9
-22,0
-31.45%
-28,7
-59,5
51.81%
-55,2
-59,5
7.12%
Net income
Million SEK
Released
Forecast
Spread
-18,9
-59,0
67.91%
-28,9
-22,0
-31.45%
-28,7
-59,5
51.81%
-55,2
-59,5
7.12%
EPS
SEK
Released
Forecast
Spread
-0,92
-2,53
63.64%
-1,40
-0,93
-50.06%
-1,39
-2,53
44.97%
-2,48
-2,14
-16.06%
Announcement Date06/05/2205/08/2209/11/2215/02/23